Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Beyer

Showing results (141-150 of 225) with videos related to

Pageof 23
Sort By:
Thrombosis and Haemostasis|June 7, 2022
Point-of-Care Assessment of Direct Oral Anticoagulation in Acute Ischemic Stroke: Protocol for a Prospective Observational Diagnostic Accuracy StudyAnnahita Sedghi, Lars Heubner, Anna Klimova, et al.
Stroke|April 28, 2025
Association of Biomarkers With Intracerebral Hematoma Expansion and Arterial Thromboembolic Events in Patients With Acute Intracranial Hemorrhage: The ANNEXA-I Biomarker SubstudyJohn W Eikelboom, Mukul Sharma, Lizhen Xu, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Predictors of Intracranial Hemorrhage Volume Expansion in Patients Receiving Factor Xa Inhibitors in ANNEXA-4: Time and Severity Matter MostMauricio Concha, Lizhen Xu, MacKenzie Horn, et al.
Internal and Emergency Medicine|May 24, 2018
Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registrySophie Testa, Walter Ageno, Emilia Antonucci, et al.
Seminars in Thrombosis and Hemostasis|January 2, 2014
Antithrombotic treatment of splanchnic vein thrombosis: results of an international registryWalter Ageno, Nicoletta Riva, Sam Schulman, et al.
Research and Practice in Thrombosis and Haemostasis|March 18, 2021
Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high- and low-dose rivaroxaban with aspirinKochawan Boonyawat, Anthonie W A Lensing, Martin H Prins, et al.
Thrombosis Research|April 27, 2020
Rates, management and outcome of bleeding complications during edoxaban therapy in daily care - results from the DRESDEN NOAC REGISTRYJan Beyer-Westendorf, Sandra Marten, Christiane Naue, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 13, 2018
Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous ThrombosisChristine G Kohn, Gary H Lyman, Jan Beyer-Westendorf, et al.
Thrombosis and Haemostasis|February 26, 2021
Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding PatientsTruman J Milling, Ben King, Patrick Yue, et al.
Thrombosis and Haemostasis|March 6, 2015
Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC RegistryJan Beyer-Westendorf, Franziska Ebertz, Kait Förster, et al.
Pageof 23

Showing results (141-150 of 225) with videos related to

Sort By:
Pageof 23
Thrombosis and Haemostasis|June 7, 2022
Point-of-Care Assessment of Direct Oral Anticoagulation in Acute Ischemic Stroke: Protocol for a Prospective Observational Diagnostic Accuracy StudyAnnahita Sedghi, Lars Heubner, Anna Klimova, et al.
Stroke|April 28, 2025
Association of Biomarkers With Intracerebral Hematoma Expansion and Arterial Thromboembolic Events in Patients With Acute Intracranial Hemorrhage: The ANNEXA-I Biomarker SubstudyJohn W Eikelboom, Mukul Sharma, Lizhen Xu, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Predictors of Intracranial Hemorrhage Volume Expansion in Patients Receiving Factor Xa Inhibitors in ANNEXA-4: Time and Severity Matter MostMauricio Concha, Lizhen Xu, MacKenzie Horn, et al.
Internal and Emergency Medicine|May 24, 2018
Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registrySophie Testa, Walter Ageno, Emilia Antonucci, et al.
Seminars in Thrombosis and Hemostasis|January 2, 2014
Antithrombotic treatment of splanchnic vein thrombosis: results of an international registryWalter Ageno, Nicoletta Riva, Sam Schulman, et al.
Research and Practice in Thrombosis and Haemostasis|March 18, 2021
Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high- and low-dose rivaroxaban with aspirinKochawan Boonyawat, Anthonie W A Lensing, Martin H Prins, et al.
Thrombosis Research|April 27, 2020
Rates, management and outcome of bleeding complications during edoxaban therapy in daily care - results from the DRESDEN NOAC REGISTRYJan Beyer-Westendorf, Sandra Marten, Christiane Naue, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 13, 2018
Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous ThrombosisChristine G Kohn, Gary H Lyman, Jan Beyer-Westendorf, et al.
Thrombosis and Haemostasis|February 26, 2021
Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding PatientsTruman J Milling, Ben King, Patrick Yue, et al.
Thrombosis and Haemostasis|March 6, 2015
Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC RegistryJan Beyer-Westendorf, Franziska Ebertz, Kait Förster, et al.
Pageof 23